Cargando…
Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
Despite potentially curative surgery pancreatic cancer has a dismal prognosis. Serum cancer antigen 19-9 (CA 19-9) correlates with tumor burden, resectability and survival in patients with pancreatic ductal adenocarcinoma. Identification of novel biomarkers may facilitate early diagnosis of pancreat...
Autor principal: | Agrawal, Shefali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465015/ https://www.ncbi.nlm.nih.gov/pubmed/28638795 http://dx.doi.org/10.5306/wjco.v8.i3.255 |
Ejemplares similares
-
Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023) -
Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
por: Di Carlo, Claudia, et al.
Publicado: (2018) -
Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021) -
Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015) -
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)